Earnings & Investor News · Week of Oct 26, 2026
Regional banks post Q3 profit gains: the week in investor news
Two community banks posted higher third-quarter profits, while robotics, media and biotech issuers reported deals, listings and trial timelines.
Regional lenders led the week's earnings reports. Ponce Financial Group says net income available to common stockholders rose to $18.0 million, or $0.76 per diluted share, in the third quarter of 2026, and Bank of Marin Bancorp says net income reached $9.9 million, or $0.62 per diluted share, citing net interest margin expansion from higher loan yields and lower deposit costs. Acumen Pharmaceuticals also reported third-quarter results, and Acurx Pharmaceuticals and Scienjoy Holding Corporation scheduled or released results of their own.
Corporate restructuring and deals made up the rest of the week. FF EAI Robotics Ecosystem says it completed its acquisition of Faraday Future's robotics business and held a Nasdaq listing ceremony and investor day on October 26. GameSquare Holdings closed its acquisition of IP assets from FanEngine Holdings and issued 2027 targets.
Ponce Financial Group, Inc.
Ponce Financial Group, Inc. Reports Third Quarter 2026 Results
Ponce Financial Group reports third-quarter 2026 net income available to common stockholders of $18.0 million, or $0.76 per diluted share, up from $8.2 million in the prior quarter and $6.2 million a year earlier. The company says the result included $57.5 million in total interest and dividend income and a $5.9 million benefit for income taxes, offset by $23.5 million in interest expense.
Bank of Marin Bancorp
Bank of Marin Bancorp
Bank of Marin Bancorp reports third-quarter 2026 net income of $9.9 million, or $0.62 per diluted share, compared with $9.2 million in the second quarter and $7.5 million a year earlier. The company attributes the gains largely to continued net interest margin expansion, and says loan growth came from organic originations supplemented by a loan pool purchase.
Scienjoy Holding Corporation
Scienjoy Holding Corporation Reports Second Quarter and First Half 2026 Unaudited Financial Results
Scienjoy Holding Corporation announced unaudited financial results for the second quarter and first half of 2026. The company describes itself as an AI technology company built on digital entertainment and enterprise AI solutions; the release excerpt provided does not include figures.
FF EAI Robotics Ecosystem Inc.
FFR to Hold Listing Ceremony and Investor Day on October 26; FFAI Announces Rescheduling of YT Jia's Investor Weekly Report to October 26
FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) scheduled its Listing Ceremony and Investor Day for October 26, where management was to outline the company's plans. Faraday Future also moved this week's Investor Weekly Report from founder and Global CEO YT Jia to the same date.
Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results
Acumen Pharmaceuticals reported third-quarter 2026 results and says it expects topline results from its ALTITUDE-AD Phase 2 study of sabirnetug in early Alzheimer's disease in November 2026. The company says it is also continuing IND-enabling work on its Enhanced Brain Delivery program, which pairs a blood-brain barrier-penetrating technology with an AβO-selective antibody.
GameSquare Holdings, Inc.
GameSquare Closes FanEngine Transaction
GameSquare Holdings completed its acquisition of sports, music and entertainment IP assets from FanEngine Holdings Ltd. after stockholders approved the deal on October 22, 2026. For 2027, GameSquare says it expects revenue of over $150 million, gross margin above 50% and adjusted EBITDA of more than $30 million.
FF EAI Robotics Ecosystem Inc.
FF EAI Robotics Ecosystem Completed its Acquisition of the Robotics Business of Faraday Future, Establish Nasdaq-Listed Humanoid and Bionic Robotics Platform
FF EAI Robotics Ecosystem says it completed its acquisition of Faraday Future's robotics business, creating a Nasdaq-listed humanoid and bionic robotics platform. The company expects October 2026 robot sales and shipments to exceed 300 units, a monthly record, bringing cumulative shipments to more than 1,100 units at a positive unit gross margin.
Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 12, 2026 Conference Call and Provide Business Update
Acurx Pharmaceuticals, a late-stage developer of a new class of antibiotics for serious bacterial infections, will discuss its third-quarter 2026 results on a conference call on November 12, 2026. The company says it will also provide a business update on the call.
This roundup is written with AI assistance from the press releases listed above, using only what they state. The releases are the companies' own announcements, not Company Agile reporting.